Stock Analysis
- Australia
- /
- Medical Equipment
- /
- ASX:NAN
ASX Growth Companies With High Insider Ownership To Watch
Reviewed by Simply Wall St
As the Australian market navigates a challenging landscape with the ASX200 slightly down and sectors like energy and financials underperforming, investors are keeping a close eye on potential opportunities amidst economic uncertainties. In such an environment, growth companies with high insider ownership can be particularly appealing, as they often indicate strong confidence from those who know the business best.
Top 10 Growth Companies With High Insider Ownership In Australia
Name | Insider Ownership | Earnings Growth |
SKS Technologies Group (ASX:SKS) | 32.4% | 24.8% |
Medallion Metals (ASX:MM8) | 13.8% | 72.7% |
Acrux (ASX:ACR) | 19.5% | 91.6% |
AVA Risk Group (ASX:AVA) | 15.7% | 77.3% |
Pointerra (ASX:3DP) | 20.8% | 126.4% |
Newfield Resources (ASX:NWF) | 31.5% | 72.1% |
Plenti Group (ASX:PLT) | 12.8% | 120.1% |
Hillgrove Resources (ASX:HGO) | 10.4% | 66.5% |
Brightstar Resources (ASX:BTR) | 16.2% | 84.6% |
Findi (ASX:FND) | 34.8% | 112.9% |
Let's review some notable picks from our screened stocks.
Australian Ethical Investment (ASX:AEF)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Australian Ethical Investment Ltd is a publicly owned investment manager with a market cap of A$631.58 million.
Operations: The company generates revenue primarily from its funds management segment, amounting to A$100.49 million.
Insider Ownership: 21.9%
Earnings Growth Forecast: 34.3% p.a.
Australian Ethical Investment is positioned for strong growth, with earnings projected to increase by 34.3% annually, outpacing the Australian market's average. Despite its revenue growth forecast of 11.6% per year being below the ideal threshold, it still surpasses market expectations. The company boasts high-quality earnings and a very high future return on equity projection of 62%. Recent AGM discussions highlighted strategic plans aligning with these optimistic forecasts, although insider trading activity remains undisclosed recently.
- Unlock comprehensive insights into our analysis of Australian Ethical Investment stock in this growth report.
- The analysis detailed in our Australian Ethical Investment valuation report hints at an inflated share price compared to its estimated value.
Cromwell Property Group (ASX:CMW)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Cromwell Property Group (ASX:CMW) is a real estate investor and fund manager operating across three continents with a global investor base, and it has a market cap of A$1.01 billion.
Operations: Cromwell Property Group's revenue is derived from Co-Investments (A$127.50 million), Investment Portfolio (A$194.30 million), and Funds and Asset Management (A$94.90 million).
Insider Ownership: 14.0%
Earnings Growth Forecast: 45.9% p.a.
Cromwell Property Group is experiencing substantial insider buying, indicating confidence in its future prospects. Despite a slower revenue growth forecast of 6.3% annually, earnings are expected to grow significantly at 45.93% per year. The company is trading at good value relative to peers, though its dividend yield of 7.79% isn't well-covered by earnings and interest payments are not fully supported by current profits. Recent AGM discussions and dividend affirmations underscore ongoing strategic commitments.
- Get an in-depth perspective on Cromwell Property Group's performance by reading our analyst estimates report here.
- Our expertly prepared valuation report Cromwell Property Group implies its share price may be lower than expected.
Nanosonics (ASX:NAN)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Nanosonics Limited is a global infection prevention company with a market cap of A$992.01 million.
Operations: The company's revenue primarily comes from its Healthcare Equipment segment, which generated A$170.01 million.
Insider Ownership: 15.4%
Earnings Growth Forecast: 24% p.a.
Nanosonics demonstrates strong growth potential with earnings forecasted to grow significantly at 24% per year, outpacing the Australian market. Despite lower profit margins compared to last year, insider activity shows more buying than selling recently, reflecting internal confidence. Revenue is expected to grow at 8.7% annually, above the market average but slower than high-growth benchmarks. The company trades at a considerable discount of 34.6% below its estimated fair value, appealing for growth-focused investors amidst ongoing board renewal processes.
- Click here to discover the nuances of Nanosonics with our detailed analytical future growth report.
- Our valuation report here indicates Nanosonics may be overvalued.
Where To Now?
- Embark on your investment journey to our 94 Fast Growing ASX Companies With High Insider Ownership selection here.
- Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
- Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Want To Explore Some Alternatives?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Nanosonics might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ASX:NAN
Nanosonics
Operates as an infection prevention company globally.